AMRX
Amneal Pharmaceuticals, Inc.
20.20$
+7.7%
vs. previous close
Closing price · As of: Sep 21, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +10.3% | +17.5% | +1.5% | +60.9% | -2.2% | +22.5% | +5.1% | +5.7% | +8.2% | +16.7% | +8.0% | |
| – | +9.2% | +14.6% | +20.6% | +86.5% | +34.5% | +7.1% | -2.9% | +7.3% | +7.7% | +15.9% | +6.2% | |
| – | +11.0% | +19.7% | -11.9% | +36.2% | -50.7% | +78.0% | +22.4% | +2.9% | +9.1% | +18.1% | +11.3% | |
| – | +28.2% | +49.6% | -6.3% | +9.6% | -3.9% | -5.8% | +10.0% | -0.4% | -6.7% | -2.1% | -2.4% | |
| – | +137.9% | -41.0% | -8.2% | +111.3% | +25.7% | +12.8% | +11.9% | +4.7% | +9.0% | +5.9% | +19.2% | |
| – | +15.9% | +16.4% | -7.0% | +46.5% | +36.5% | -10.7% | +14.7% | +43.8% | -25.6% | +16.9% | -7.5% | |
| – | +1.9% | +25.4% | -14.0% | -108.0% | – | – | +67.5% | -162.2% | – | +22.0% | +69.7% | |
| – | – | – | +28.5% | +102.0% | +17.2% | -13.2% | -6.6% | +16.2% | +33.0% | +22.8% | -6.8% | |
| – | -2.1% | +22.3% | -20.2% | -218.3% | – | – | – | -891.1% | – | – | – | |
| – | +227.2% | +9.0% | -63.0% | -171.0% | – | -127.2% | – | -40.5% | +26.9% | +123.2% | -40.2% | |
| – | -4.2% | +22.4% | -19.2% | -201.2% | – | – | -88.3% | -1,323.5% | – | – | – | |
| – | +3.9% | +21.5% | -11.7% | -107.3% | – | +122.7% | +16.1% | +9.8% | +13.8% | -12.2% | +37.3% |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.